Evidence map›Paper›PMID 37558269›Full record

ArticleBMJ global health2023

Experiences and challenges of African traditional medicine: lessons from COVID-19 pandemic.

Polydor Ngoy Mutombo, Ossy Muganga Julius Kasilo, Peter Bai James, Jon Wardle, Olobayo Kunle, David Katerere, Charles Wambebe, Motlalepula Gilbert Matsabisa, Mohammed Rahmatullah, Jean-Baptiste Nikiema and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Addressing communication dynamics in traditional medicine use disclosure to physicians.African journal of primary health care & family medicine · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Antiviral Activity of Medicinal Plant ExtractsPathogens (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Mpox and oral health among children in Africa.Frontiers in oral health · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 10 countries.

Polydor Ngoy MutomboFaculty of Health, National Centre for Naturopathic Medicine, Southern Cross University, Lismore, New South Wales, Australia polydorngoymutombo@gmail.com.ORCID 0000-0003-0208-3770
Ossy Muganga Julius KasiloUniversal Health Coverage Life Course Cluster, World Health Organization Regional Office for Africa, Brazzaville, Congo.ORCID 0000-0003-1538-9293
Peter Bai JamesFaculty of Health, National Centre for Naturopathic Medicine, Southern Cross University, Lismore, New South Wales, Australia.
Jon WardleFaculty of Health, National Centre for Naturopathic Medicine, Southern Cross University, Lismore, New South Wales, Australia.
Olobayo KunlePharmaceutical Technology and Raw Materials Development, National Institute for Pharmaceutical Research and Development, Abuja, Federal Capital Territory, Nigeria.
David KatererePharmaceutical Science, Tshwane University of Technology, Pretoria, South Africa.
Charles WambebePharmacology & Therapeutics, School of Biomedical Sciences, International Biomedical Research Institute (IBRI), Abuja, Nigeria.
Motlalepula Gilbert MatsabisaPharmacology, University of the Free State, Bloemfontein, Free State, South Africa.
Mohammed RahmatullahBiotechnology & Genetic Engineering, University of Development Alternative, Dhaka, Bangladesh.
Jean-Baptiste NikiemaMedicines Supply, Health Infrastructure and Equipment Maintenance (MIM) Unit, Universal Health Coverage/Life Course Cluster, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Immaculee MukankubitoMedicines Supply, Health Infrastructure and Equipment Maintenance (MIM) Unit, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Rick SheridanEMSKE Phytochem, Nairobi, Kenya.
Rokia SanogoMédecine Traditionnelle, Institut National de Recherche en Sante Publique, Bamako, Mali.
Veeranoot NissapatornSchool of Allied Health Sciences and World Union for Herbal Drug Discovery (WUHeDD), Walailak University, Thai Buri, Thailand.
Chaisith SivakornIntensive Care Unit, University College London Hospitals NHS Foundation Trust, London, UK.
Satyajit TripathyPharmacology, University of the Free State, Bloemfontein, Free State, South Africa.
Ramesh GoyalSchool of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Delhi, India.
Mahaveer DhobiSchool of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Delhi, India.
Southern Cross University · AUWorld Health Organization Regional Office for Africa · CGDelhi Pharmaceutical Science and Research University · INUniversity of the Free State · ZAInstitut National de Recherche en Santé Publique · MLKenya Plant Health Inspectorate Services · KENational Institute for Pharmaceutical Research and Development · NGTshwane University of Technology · ZAUniversity College London Hospitals NHS Foundation Trust · GBUniversity of Development Alternative · BDWalailak University · TH

Funding

World Health Organization 001
6 · The paper itself

Abstract

Management of COVID-19 in Africa is challenging due to limited resources, including the high cost of vaccines, diagnostics, medical devices and routine pharmaceuticals. These challenges, in addition to wide acceptability, have resulted in increased use of herbal medicines based on African traditional medicines (ATMs) by patients in Africa. This is in spite of the often-significant gaps in evidence regarding these traditional medicines as to their efficacy and safety for COVID-19. African scientists, with some support from their governments, and guidance from WHO and other bodies, are addressing this evidence gap, developing and testing herbal medicines based on ATMs to manage mild-to-moderate cases of COVID-19. Such efforts need further support to meet public health needs.

Indexed as

COVID-19AfricaHumansMedicine, African TraditionalPandemicsPlant ExtractsPlant ExtractsCOVID-19Health policyPharmacologyPublic HealthTreatment

Identifiers

PMID37558269
PMCPMC10414097
OpenAlexW4385690254

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.